DERM

시간 외 거래: 6.72

Journey Medical Corp (DERM)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Journey Medical Corp Stock (DERM) Company Profile

Journey Medical Corp

Healthcare (1080)

480-434-6670

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

최신 SEC 제출 서류

DERM's Discussions on Twitter

Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DERM Journey Medical Corp	6.72	177.05M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-25	개시	H.C. Wainwright	Buy
2025-07-30	재개	B. Riley Securities	Buy
2024-08-22	개시	Rodman & Renshaw	Buy
2024-06-28	재개	ROTH MKM	Buy
2021-12-07	개시	B. Riley Securities	Buy

Journey Medical Corp 주식(DERM)의 최신 뉴스

Journey Medical Corp (DERM) 재무 분석

Journey Medical Corp (DERM)

Journey Medical Corp Stock (DERM) Company Profile

Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Journey Medical Corp 주식(DERM)의 최신 뉴스

Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey

Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - marketbeat.com

Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction - Sahm

Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks

Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times

Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - marketbeat.com

Why is Journey Medical stock rallying today? - Investing.com

Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - marketbeat.com

Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance

Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Australia

DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus

Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance

Journey Medical Q2 Earnings Call Highlights - marketbeat.com

Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance

Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com

Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com

Journey Medical (NASDAQ:DERM) Posts Earnings Results, Beats Expectations By $0.04 EPS - marketbeat.com

Journey Medical (DERM) grows Emrosi sales but flags going concern risk - Stock Titan

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Yahoo Finance

Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Val - GuruFocus

Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Value Sees 6% Upside - Yahoo Finance

From the hardwood to healthcare: CEO Stephen Flatt’s journey to the top of long-term care - McKnight's Long-Term Care News

Journey Medical Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Yahoo Finance

Journey Medical (DERM) Expected to Post Earnings on Tuesday - marketbeat.com

Vanguard Capital Management (DERM) discloses 774,556 Journey Medical shares in 13G/A - Stock Titan

Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

DERM|Journey Medical Corp|Price:6.360|Chg%:+0.170 - TradingKey

Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Journey Medical Corp (DERM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Journey Medical Corp (DERM) Valuation: PE, PB & Fair Value Analysis - TradingKey

Journey Medical Corp (DERM) Cash Flow - TradingKey

Journey Medical Corp|Price:6.190|Chg%:-0.390 - TradingKey

DERM stock holds focus on Journey Medical Corp results - Ad-hoc-news.de

WASATCH ADVISORS LP Acquires Additional Shares in Journey Medica - GuruFocus

DERM Stock Price, Quote & Chart - ChartMill

Mount Grace Hospitals Launches Medico Concierge Kiosk and Patient Portal to Transform Digital Patient Journey - Daily Tribune

Top medical emergencies covered under travel medical insurance - Adgully.com

Journey Medical (DERM) gains 13.3% shareholder in Wasatch Advisors - Stock Titan

Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Journey Medical Corp focuses on dermatology growth. DERM stock reflects a specialized niche strategy - Ad Hoc News

Journey Medical (DERM) Falls Over 6% as Shares Approach Key Support LevelSafe Entry Stocks - dars.gov.et

Form 4 Journey Medical Corp For: 2 July By Investing.com - Investing.com Canada

Journey Medical (DERM) grants director 50,000 restricted stock units - Stock Titan

Journey Medical Corp (DERM) 재무 분석

매출

순이익

현금흐름

주당 순 이익

DERM과 유사한 종목